Key facts
- The Wegovy weight loss pill is now available for private purchase in UK pharmacies.
- Wegovy contains the active ingredient semaglutide.
- It is a once-daily pill.
- The pill is intended for individuals with a BMI of 30 or above.
- It is also for individuals with a BMI of 27-30 who have weight-related health conditions.
- A consultation is required to obtain the pill.
- Wegovy works by mimicking a gut hormone to reduce appetite.
- The pill is similarly effective to the injectable version of semaglutide.
- The pill has specific administration requirements.
The once-daily Wegovy weight loss pill, containing semaglutide, is now available for private purchase in UK pharmacies. This medication is intended for individuals who meet specific criteria related to their Body Mass Index (BMI). Specifically, it is for those with a BMI of 30 or above, or a BMI between 27 and 30 who also have weight-related health conditions. Access to the pill requires a consultation with a healthcare professional. The mechanism of action for Wegovy involves mimicking a gut hormone to reduce appetite. The oral version is reported to be similarly effective to the injectable semaglutide, although it has distinct administration requirements that users must follow. The availability in the UK marks a new option for individuals seeking weight management solutions through pharmacological intervention.